Scientists map immune cells in rare cancer to boost treatment

NCT ID NCT07561190

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at the immune system inside malignant pleural mesothelioma, a rare and hard-to-treat cancer. Researchers will analyze tumor samples from 300 adults to understand why immunotherapy helps only some patients. The goal is to find clues that could make these treatments more effective in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL MESOTHELIOMA (MPM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pleural mesothelioma Mesothelioma, Malignant

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Azienda Ospedaliera Universitaria Luigi Vanvitelli, Napoli

    RECRUITING

    Naples, Italy

    Contact Email: •••••@•••••

  • Azienda Ospedaliera Universitaria Policlinico Rodolico San Marco di Catania

    RECRUITING

    Catania, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Azienda USL IRCCS di Reggio Emilia

    RECRUITING

    Reggio Emilia, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    RECRUITING

    Roma, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••